APA (7th ed.) Citation

Kashii, M., Kamatani, T., Nagayama, Y., Miyama, A., Tsuboi, H., & Ebina, K. (2023). Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis. Osteoporosis international, 34(3), 563-572. https://doi.org/10.1007/s00198-022-06642-1

Chicago Style (17th ed.) Citation

Kashii, Masafumi, Takashi Kamatani, Yoshio Nagayama, Akira Miyama, Hideki Tsuboi, and Kosuke Ebina. "Baseline Serum PINP Level Is Associated with the Increase in Hip Bone Mineral Density Seen with Romosozumab Treatment in Previously Untreated Women with Osteoporosis." Osteoporosis International 34, no. 3 (2023): 563-572. https://doi.org/10.1007/s00198-022-06642-1.

MLA (9th ed.) Citation

Kashii, Masafumi, et al. "Baseline Serum PINP Level Is Associated with the Increase in Hip Bone Mineral Density Seen with Romosozumab Treatment in Previously Untreated Women with Osteoporosis." Osteoporosis International, vol. 34, no. 3, 2023, pp. 563-572, https://doi.org/10.1007/s00198-022-06642-1.